The latest report by IMARC Group, titled “Protein Labeling Market Report by Labeling Method (In-Vitro Labeling, In-Vivo Labeling), Product (Reagents, Kits, Services), Application (Cell-based Assays, Fluorescence Microscopy, Mass Spectrometry, Immunological Techniques, Protein Microarray), and Region 2025-2033,” finds that the global protein labeling market size reached USD 2.6 Billion in 2024. Protein labeling is the process of using appropriate molecular labels to detect, purify and characterize proteins and their binding partners. It is performed by creating self-labeling tags and genetic fusions, which impart distinctive properties for selective protein visualization, manipulation, and entrapment within complex biochemical environments. The labels are attached covalently to the desired molecule, thus simplifying the processes of detection and purification. Moreover, the protein labeling process helps detect various proteins in tissues, cells, and biochemical assays as they are essential biomolecules vital for the functioning of living organisms.
Global Protein Labeling Market Trends:
The global protein labeling market is driven by increasing advancement in proteomics research. For instance, research and development (R&D) activities have led to improvements in mass spectrometry workflows and miniaturization of biochips and protein microarray in proteomics, which have escalated the demand for protein labeling techniques. The market is also fueled by the rising adoption of modern molecular biology and bioengineering tools to enhance the knowledge of functional mechanisms on a subcellular scale. Consequently, it facilitates improvements in drug development, diagnosis, and therapy applications. Besides this, the extensive investments by the governments of various countries in the healthcare sector are propelling the market growth. Furthermore, the growing competition and the entry of small companies have resulted in the launch of new products, which can be customized according to the requirements of researchers. Looking forward, the market value is projected to reach USD 6.0 Billion by 2033, expanding at a CAGR of 9.1% during 2025-2033.
Market Summary:
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Labeling Method, Product, Application, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Agilent Technologies Inc., Cytiva (Danaher Corporation), F. Hoffmann-La Roche Ltd. (Roche Holding AG), Jena Bioscience GmbH, LGC Limited, LI-COR Inc., Merck KGaA, New England Biolabs, PerkinElmer Inc., Promega Corporation and Thermo Fisher Scientific Inc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: https://www.imarcgroup.com
Follow us on twitter: @imarcglobal